COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.
Neil H SegalJeanne TieScott KopetzMichel DucreuxEric ChenRodrigo DienstmannAntoine HollebecqueMatthew J ReilleyElena Elez FernandezJan CosaertJason CainYee Soo-HooNicola HewsonZachary A CooperRakesh KumarJosep TaberneroPublished in: British journal of cancer (2024)
NCT04068610.